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We present a 56-year-old woman affected by a large leiomyosarcoma originating from the suprarenal inferior vena cava
(IVC). A computed tomography (CT) scan revealed near obstruction of the IVC and involvement of the right renal vein.
The patient underwent successful en bloc resection of the tumor, right kidney, right adrenal gland, and IVC. Caval
reconstruction was performed using a non-type specific allograft, followed by left renal vein re-implantation. The patient
tolerated the procedure well without any complications. The use of an IVC allograft allowed for continued graft patency,
without the need of immunosuppression or long-term anticoagulation. However, local recurrence did occur. (J Vasc
Surg 2007;46:140-3.)Vascular leiomyosarcomas are rare malignant tumors
that originate from the smooth muscle cells of the media.
These tumors constitute 2% of all leiomyosarcomas and
have a five times greater propensity to affect veins than
arteries.1 Leiomyosarcoma of the inferior vena cava (IVC)
was initially described in 1871 by Perl.2 It is now known
that these tumors are the most common malignant tumors
of the IVC and 60% of those of vascular origin affect the
IVC.3 Though disease-free survival remains marginal, it is
widely accepted that resection and reconstruction of the
affected region is required for optimal treatment.1,4-6 Re-
construction of the IVC with biosynthetic and autoge-
neous grafts have been reported in the literature. In this
article, we report a new approach to IVC reconstruction
utilizing a non-type specific IVC allograft, without the
need of adjunct immunosupression.
CASE REPORT
A previously healthy 56-year-old woman presented with right-
sided abdominal pain. On physical examination, the patient was
afebrile, with only mild tenderness and no peritoneal signs. The
patient underwent an abdominal computed tomography (CT)
scan that demonstrated a large lobulated mass between the supra-
renal inferior vena cava (IVC) and the right kidney (Fig 1).
Superiorly, the mass extended posterior to the left lobe of the liver
and compressed the IVC medially. The mass appeared to originate
from the IVC and had characteristics of a leiomyosarcoma. No
metastases were identified upon staging. A subsequent venacavog-
raphy revealed narrowing of the IVCwithout an intra-caval throm-
bus (Fig 2). Due to the close approximation of the mass to
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140surrounding organs, there was concern that extensive caval resec-
tion would be necessary for complete resection.
Following an appropriate approval from the Institutional Re-
view Board (IRB), the patient underwent the following surgical
reconstructive procedure. The abdomen was entered via bilateral
subcostal incisions. The right colon was reflected medially and all
of the azygous branches were divided. The right and left lobes of
the liver were extensively mobilized to expose the inferior vena
cava. The mass was noted to arise from the right wall of the IVC
and included the right renal vein. Taking into account the extent of
the mass, an en bloc resection of the right kidney, right adrenal
gland, and the IVC, from above the confluence of the iliac veins, to
below the hepatic veins, was performed. Hemostatic control of the
retrohepatic and infrarenal IVC was achieved with clamps. The
junction of the left renal vein and IVC cuff was preserved. Recon-
struction was performed using a fresh, non-type specific, inferior
vena cava allograft (Fig 3). The left renal vein was re-implanted in
an end-to-side fashion onto the graft. Histology confirmed the
diagnosis of a leiomyosarcoma with negative margins. The pa-
tient’s renal function remained normal and she was discharged
home on the seventh postoperative day without any complications.
No immunosuppression was utilized and full anticoagulation with
coumadin was used for only 1 month. At 14-month follow-up, the
patient was doing well without any lower extremity edema. CT
scan reconstruction with venous phase was performed, revealing a
widely patent inferior vena cava. However, local recurrence was
apparent within the renal fossa.
The caval allograft used in this patient was procured from a
cadaveric organ donor. The techniques of allograft preservation are
briefly described. Following the allograft procurement from an
organ donor, the vascular allograft was kept in University of
Wisconsin preservation solution (ViaSpan; DuPont Pharma, Wil-
mington, Dele). The vessel was treated within 24 hours with
RPMI-1640 with 2.05 mM L-glutamine (JRH Biosciences; Le-
nexa, Kan) containing cefoxitin (240 g/mL), lincomycin (120
g/ml), vancomycin 50 g/ml), and polymyxin B (100 g/ml)
for 24 hours at 10°C temperature. The caval allografts are
transferred sterilely to fresh RPMI-1640 with 2.05 mM L-
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days in case they are needed to vascular reconstruction.
DISCUSSION
The inferior vena cava is the most commonly involved
vessel in leiomyosarcoma and is usually a high-grade tu-
mor.1 In one study, primary IVC leiomyosarcoma ac-
counted for 0.5% of all soft tissue sarcomas.7 Mingoli et al
Fig 1. Computed tomography image reveals a large leiomyosar-
coma (arrow) originating from the inferior vena cava (dashed
arrow).
Fig 2. Venography shows compression of the inferior vena cava
by a large mass. No thrombus is visualized, and the IVC is patent.described three regions within the IVC for tumor involve-ment: (1) Upper segment: from the right atrium to the
hepatic veins (20%), (2) Middle segment: from the hepatic
veins to the renal veins (44%), and (3) Lower segment:
infrarenal (37%).8 They demonstrated that the risk of death
is higher for proximal segmental disease and lowest for
middle segment involvement.8 Patients present with a myr-
iad of symptoms, including abdominal pain, abdominal
mass, pedal edema, weight loss, and Budd-Chiari syn-
drome.6 Leiomyosarcoma of the IVC has a female predom-
inance and a mean age of 56 years.9
In 1992, the International Registry of Inferior Vena
Cava Leiomyosarcomas was established to study the patho-
genesis and natural history of the tumor.8 The authors
determined that there is an increased risk of death associ-
ated with upper IVC segment involvement, lower limb
edema, Budd-Chiari syndrome, intraluminal tumor
growth, and IVC occlusion.8 On the other hand, the
presence of abdominal pain and the absence of a palpable
abdominal mass are associated with good outcomes.6 This
disease is associated with a highmorbidity and certain death
without resection. Therefore, the goal of management is to
achieve local control, maintain venous return and to pre-
vent recurrence.9 Radical resection of the IVC, therefore,
serves as the only chance for survival.6 When the IVC is
ligated and not reconstructed, thrombus may form in the
blind portion of the IVC and may even extend above the
hepatic vein resulting in Budd-Chiari syndrome.10 How-
ever, some authors advocate resection without reconstruc-
tion when the IVC is occluded or extensively scarred,
well-developed venous collaterals have formed, or for those
requiring concomitant intestinal resection.11,12 As such,
complete resection and reconstruction of the IVC is widely
recommended and accepted as the mainstay treatment for
leiomyosarcoma.
Methods of reconstruction consist of simple repair,
Fig 3. Reconstruction of the IVC using an allograft (large arrow),
prior to left renal vein (small arrow) anastomosis.patch repair, and segmental replacement.13 Primary repair
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be prevented by patch grafting the defect.14 Several mate-
rials may be utilized for patch grafting. The utilization of
part of the pericardium as an autograft is being advocated
since it is readily available and accessible.15 Preliminary
results have also shown that an autogenous peritoneo-
fascial graft may be a suitable alternative to current biosyn-
thetic materials.14 The graft is comprised of a strip of
peritoneum and the posterior rectus fascia.16 In theory, the
mesothelial lining of the peritoneo-fascial graft may pro-
mote vessel patency by the production of prostacyclin and
promotion of thrombolytic activity.16 Segmental replace-
ment can be achieved with autogeneous vein or prosthetic
grafts, such as polytetrafluoroethylene (PTFE), Teflon, or
Dacron grafts.5,17 It is presumed that ringed PTFE grafts
resist respiratory compression and prevent collapse, which
may be a factor in the promotion of thrombosis.18 Place-
ment of a graft smaller than the native IVC has also been
advocated because the ensuing high velocity blood flow
may minimize blood-prosthetic interactions that promote
thrombosis.18 On the other hand, others advocate the use
of grafts larger than 16 mm in diameter because the PTFE
grafts tend to form a thick pseudo-intima that may result in
obstruction.19 Glutaraldehyde-treated bovine pericardium
has also been reported as an effective alternative, due to a
lower thrombogenicity seen in repair of congenital cardio-
myopathies.20 However, to our knowledge there have been
no reported cases of IVC reconstruction utilizing an IVC
allograft from a nonliving donor.
While lateral venorrhaphy with patch angioplasty is the
preferred technique of repair, this option is ideally suited in
cases of caval trauma or limited caval compression caused
by tumor from adjacent organs. In contrast, primary IVC
malignancy, such as leiomyosarcoma in our patient, typi-
cally involves a significant caval segment that is rarely ame-
nable to local resection with caval patch angioplasty. Under
such a circumstance, caval resection with interposition by-
pass grafting is the preferred technique of repair. Our
patient has been followed closely with radiographic surveil-
lance and has continued to show no signs of thrombosis at
14 months after surgery. The use of an allograft prevented
the need for long-term anticoagulation, including aspirin,
clopidogrel, and warfarin. Also, the patient did not require
immunosuppressive therapy. She did not experience any
immune reactions or infections. Although the effectiveness
cannot be based on one case study, it is the authors’ belief
that IVC allograft is a useful conduit for caval reconstruc-
tion. The choice of graft material for IVC reconstruction
should not alter tumor recurrence rates or long-term sur-
vival.
Radical tumor resection has resulted in 5- and 10-year
survival rates of 49.4% and 29.5%, respectively.21 Perioper-
ative mortality for this procedure ranges between 0 to
15%.3,7,8 Despite advances in medical therapy and opera-
tive techniques, the major obstacle of preventing recur-
rence has been illusive. Local tumor recurrence has been
found to be as high as 57.3%.21 Although it was initially
reported that high-grade tumors increased the risk ofdeath, it has been found that tumor grade did not predict
recurrence or survival.6,9 Similarly, extended venous resec-
tion does not influence local recurrence nor does it affect
long-term outcome.21 A retrospective analysis conducted
at UCLA also found no difference in survival based on age,
gender, tumor size, and lymph node status.9 However,
they did report a discernable difference when the resected
margins were positive. None of the patients with positive
margins were alive at 5 years, compared with 68% of those
with negative margins.9 Initially, it was reported that radi-
ation therapy had no effect on recurrence or survival.6
However, a recent retrospective study has shown promise
that high dose, intraoperative radiation improves local con-
trol.7
Treating leiomyosarcoma of the inferior vena cava re-
mains a challenge. Over the years, new techniques have
resulted in decreased morbidity and mortality associated
with operative management, yet local recurrence remains
high. The rarity of this disease poses a great obstacle in its
investigation. Prospective randomized trials will remain
illusive, so information will continue to be obtained from
retrospective studies and case reports. As such, we have
shown that our method for reconstructing the vena cava
with an IVC allograft provides good patency without re-
quiring long-term anticoagulation or immunosuppression.
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